Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale
Yıl: 2019 Cilt: 28 Sayı: 2 Sayfa Aralığı: 120 - 126 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2019.3371 İndeks Tarihi: 21-07-2020
Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale
Öz: Objective: The monitoring of immunosuppressive medication adherence is an important issue for solid organ transplantpatients. In Turkey, there has been no valid and reliable measurement tool specific to transplantation for evaluation ofmedication adherence. The aim of this methodological study was to develop and psychometrically test Immunosuppressive Medication Adherence Scale.Materials and Methods: The Immunosuppressive Medication Adherence Scale was developed, and its validity and reliability were examined using data from 200 solid organ transplant patients. An expert panel evaluated the content validity,and factor analysis was used to evaluate the construct validity. Internal consistency analysis was performed to evaluate thereliability of the scale, and item–total correlations were evaluated.Results: As a result of exploratory factor analysis, all 11 items were found to be collected in a single dimension, and factorloadings varied between 0.32 and 0.87. All scale items had a good positive significant correlation with the total scale score.Content validity was evidenced by obtaining the views of 13 experts (0.80 content validity index). Cronbach’s α was 0.61.Conclusion: The Immunosuppressive Medication Adherence Scale has acceptable internal consistency, good content, andconstruct validity. The scale is appropriate for use in clinical practice settings and research to evaluate immunosuppressivemedication adherence of solid organ transplant patients.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Dew MA, Di Martini AF, De Vito Dabbs A, Myaskovsky L, Steel J, Unruh M, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 83: 858-73. [CrossRef]
- 2. Germani G, Lazzaro S, Gnoato F, Senzolo M, Borella V, Rupolo G, et al. Nonadherent behaviors after solid organ transplantation. Transplant Proc 2011; 43: 318-23. [CrossRef]
- 3. Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: Associations with medication beliefs and illness perceptions. Transplantation 2012; 93: 958-63. [CrossRef]
- 4. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: A systematic review. Transpl Int 2009; 22: 780-97. [CrossRef]
- 5. World Health Organization. Adherence to long-term therapies (Internet). Geneva: World Health Organization; 2003. Available from: http:// www.who.int/chp/knowledge/publications/adherence_report/en/
- 6. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011; 86: 304-14. [CrossRef]
- 7. Fine R, Becker Y, De Geest S, Eisend H, Ettengere R, Evanset R, et al. Nonadherence consensus conference summary report. Am J Transplant 2009; 9: 35-41. [CrossRef]
- 8. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; CD000011. [CrossRef]
- 9. Morrissey PE, Flynn ML, Lin S. Medication noncompliance and its implications in transplant recipients. Drugs 2007; 67: 1463-81. [CrossRef]
- 10. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: What we know and what we need to further know. Med Care 2005; 43: 517-20. [CrossRef]
- 11. De Bleser L, Dobbels F, Berben L, Vanhaecke J, Verleden G, Nevens F, et al. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl Int 2011; 24: 882-91. [CrossRef]
- 12. Dobbels F, Berben L, De Geest S, Drent G, Lennerling A, Whittaker C, Kugler C. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: A systematic review. Transplantation 2010; 90: 205-19. [CrossRef]
- 13. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-35. [CrossRef]
- 14. Laufs U, Rettig-Ewen V, Bohm M. Strategies to improve drug adherence. Eur Heart J 2011; 32: 264-8. [CrossRef]
- 15. Russell C, Conn V, Ashbaugh C, Madsen R, Wakefield M, Webb A, et al. Taking immunosuppressive medications effectively (TIMELink): A pilot randomized controlled trial in adult kidney transplant recipients. Clin Transplant 2011; 25: 864-70. [CrossRef]
- 16. Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008; 8: 616-26. [CrossRef]
- 17. DiMatteo MR. Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 2004; 42: 200-9. [CrossRef]
- 18. Guadagnoli E, Velicer WF. Relation of sample size to the stability of component patterns. Psychol Bull 1988; 103: 265-75. [CrossRef]
- 19. MacCallum RC, Widaman KF, Zhang S, Hong S. Sample size in factor analysis. Psychol Methods 1999; 4: 84-99. [CrossRef]
- 20. DeVellis RF. Scale Development Theory and Applications, 3rd edn. USA, Washington DC: SAGE Publications; 2014.
- 21. Tezbasaran A. Likert Scale Preparation Guide. Mersin: Association of Turkish Psychologist, 2008.
- 22. Suhr DD. Exploratory or confirmatory factor analysis? Colorado: University of Northern Colorado, 2006.
- 23. Cronbach LJ, Warrington WG. Time-limit tests: Estimating their reliability and degree of speeding. Psychometrika 1951; 16: 167-88. [CrossRef]
- 24. Muthen & Muthen: MPlus (Version 6). Los Angeles, CA; 2006.
- 25. Lawshe CH. A quantitative approach to content validity. Pers Psychology 1975; 28: 563-75. [CrossRef]
- 26. Sencan H. Social and Behavioral Measures of Reliability and Validity. Ankara, Turkey: Seckin Publishing, 2005.
- 27. Tavsancil E. Measurement of Attitudes and Data Analysis with SPSS 2014. Ankara, Turkey: Nobel Academic Publishing, 2014.
- 28. Norman GR, Streiner DL. Biostatistics: The Bare Essentials. St Louis: Mosby, 1994.
- 29. Nunnally JC, Bernstein IH. Psychometric Theory (3rd ed). USA, New York: McGraw-Hill, 1994.
- 30. Alpar R. Applied Statistics With Examples in Spor, Health and Educational Sciences and Validity-Reliability. Ankara, Turkey: Detay Anatolia Academic Publishing, 2010.
| APA | Ozdemir Koken Z, TALAS M, Gokmen D (2019). Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. , 120 - 126. 10.5152/turkjnephrol.2019.3371 |
| Chicago | Ozdemir Koken Zeliha,TALAS Melek Serpil,Gokmen Derya Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. (2019): 120 - 126. 10.5152/turkjnephrol.2019.3371 |
| MLA | Ozdemir Koken Zeliha,TALAS Melek Serpil,Gokmen Derya Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. , 2019, ss.120 - 126. 10.5152/turkjnephrol.2019.3371 |
| AMA | Ozdemir Koken Z,TALAS M,Gokmen D Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. . 2019; 120 - 126. 10.5152/turkjnephrol.2019.3371 |
| Vancouver | Ozdemir Koken Z,TALAS M,Gokmen D Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. . 2019; 120 - 126. 10.5152/turkjnephrol.2019.3371 |
| IEEE | Ozdemir Koken Z,TALAS M,Gokmen D "Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale." , ss.120 - 126, 2019. 10.5152/turkjnephrol.2019.3371 |
| ISNAD | Ozdemir Koken, Zeliha vd. "Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale". (2019), 120-126. https://doi.org/10.5152/turkjnephrol.2019.3371 |
| APA | Ozdemir Koken Z, TALAS M, Gokmen D (2019). Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. Turkish journal of nephrology (Online), 28(2), 120 - 126. 10.5152/turkjnephrol.2019.3371 |
| Chicago | Ozdemir Koken Zeliha,TALAS Melek Serpil,Gokmen Derya Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. Turkish journal of nephrology (Online) 28, no.2 (2019): 120 - 126. 10.5152/turkjnephrol.2019.3371 |
| MLA | Ozdemir Koken Zeliha,TALAS Melek Serpil,Gokmen Derya Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. Turkish journal of nephrology (Online), vol.28, no.2, 2019, ss.120 - 126. 10.5152/turkjnephrol.2019.3371 |
| AMA | Ozdemir Koken Z,TALAS M,Gokmen D Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. Turkish journal of nephrology (Online). 2019; 28(2): 120 - 126. 10.5152/turkjnephrol.2019.3371 |
| Vancouver | Ozdemir Koken Z,TALAS M,Gokmen D Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale. Turkish journal of nephrology (Online). 2019; 28(2): 120 - 126. 10.5152/turkjnephrol.2019.3371 |
| IEEE | Ozdemir Koken Z,TALAS M,Gokmen D "Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale." Turkish journal of nephrology (Online), 28, ss.120 - 126, 2019. 10.5152/turkjnephrol.2019.3371 |
| ISNAD | Ozdemir Koken, Zeliha vd. "Development and Psychometric Testing of the Turkish Immunosuppressive Medication Adherence Scale". Turkish journal of nephrology (Online) 28/2 (2019), 120-126. https://doi.org/10.5152/turkjnephrol.2019.3371 |
